Coronavirus: Dutch hospitals run out of remdesivir anti-viral treatment.

The Irish Times

The Irish Times online. Latest news including sport, analysis, business, weather and more from the definitive brand of quality news in Ireland.

As a second wave of Covid-19 sweeps the country, Dutch hospitals have run out of one of the key anti-viral drugs being used to treat the pandemic – and there are concerns that this could indicate the start of a Europe-wide shortage.

Those concerns are based on the fact that remdesivir – which reduces the recovery time of moderately ill patients with breathing difficulties and was given to US president Donald Trump during his hospital stay – is purchased centrally for EU countries by the European Commission.

Both the Dutch public health institute and the health ministry have confirmed that the drug is now out of stock despite talks about the worsening problem going on “for weeks” with the EU, which also distributes the treatment to member states.

In an unusually frank comment, a spokesperson for the health ministry described the commission’s failure to manage supplies in an ongoing crisis situation as “very annoying”.


Asked if it was the ministry’s understanding that other EU countries were now facing the same shortage, the spokesperson could only say that that remained “unclear”.

Remdesivir was originally developed by the American pharmaceuticals giant Gilead to treat Ebola. It was approved for emergency use in treating Covid-19 in May in the United States, and the following month in the European Union.

A phase 3 clinical trial showed that patients with moderate Covid-19 infections who received a five-day course of remdesivir – as Mr Trump did – were more likely to get better after 11 days than those receiving standard treatment. The trial showed it also helps patients with pneumonia.

The root of the current shortage appears to be that, having approved the drug, the US then bought up 500,000 doses in July, before the EU managed to place its order – and this has made it considerably more difficult to source in the rest of the world.

Doctors in the Netherlands insist they are not yet alarmed at the shortage of the virus inhibitor, which they say could be “unpleasant” rather than “a disaster”. They don’t know how long it will last.

“This drug doesn’t save lives, but it does reduce the length of time patients spend in hospital, which is good for them and for the hospital system,” said Dr Mark de Boer, an infectious diseases specialist involved in drawing up the national coronavirus treatment guidelines.

Новини по темі

US reports record Covid-related death toll

Daily Covid cases hit 200,000 with 2,885 deaths reported on Wednesday

Warning that significant gaps remain in talks between Brexit negotiators.

Johnson still intends on Monday to restore to Internal Market Bill the treaty-breaking clauses that were removed by House of Lords

European and US experts question UK’s vaccine fast-track.

Fauci claims US is proceeding ‘the correct way’ on vaccine while the UK ‘did not do it as carefully’

Whiff of a Brexit fisheries win would bring joy to Johnson.

London Letter: British PM would have little difficulty pushing for the nuclear option

Austria tightens borders and imposes ski restrictions for Christmas.

Stricter measures come amid figures showing record level of 2,431 deaths in one week

Bangladesh begins moving Rohingya families to remote island.

Rights groups call for relocation to be halted on safety concerns and lack of consent from refugees

Explosion at Bristol water plant causes ‘number of casualties’.

Blast at treatment works in Avonmouth believed to have involved chemical tanks

1 13

Four killed in explosion at Bristol water treatment plant.

No ongoing safety concerns after ‘tragic incident’ at Avonmouth facility, say police

Liberian rebel commander in outburst at start of trial for cannibalism, rape.

Alieu Kosiah(45)is also accused of recruiting a 12-year-old as bodyguard during civil war

Swedish woman cleared of imprisoning son for decades.

Authorities to close investigation after finding no evidence man in 40s held against will